Featured
11/05/2025
Access in all areas? A round-up of developments in market access and health technology assessment: part 10 Journal of Comparative Effectiveness Research. 2025;14(11):e250138
https://www.ncbi.nlm.nih.gov/pubmed/?otool=iaufhhslib&term=40955618
Applying Evidence-Based Medicine Standards to Digital Tools American Journal of Health Promotion. 2025:8901171251394242
https://www.ncbi.nlm.nih.gov/pubmed/?otool=iaufhhslib&term=41151068
Bridging the patient gap: exploring generative AI to support meaningful patient involvement in health technology assessment Journal of Comparative Effectiveness Research. 2025:e250150
https://www.ncbi.nlm.nih.gov/pubmed/?otool=iaufhhslib&term=41185973
Early health technology assessment: current and future perspectives from a health technology assessment agency International Journal of Technology Assessment in Health Care. 2025;41(1):e68
https://www.ncbi.nlm.nih.gov/pubmed/?otool=iaufhhslib&term=40958666
Editorial: Translation of health technology reassessment and its outputs of disinvestment, de-implementation and de-adoption of drugs and medical devices in practice-what have we learned? Frontiers in Pharmacology. 2025;16:1700196
https://www.ncbi.nlm.nih.gov/pubmed/?otool=iaufhhslib&term=41158131
Engaging stakeholders along health technology assessment pathways: a scoping review of international practice International Journal of Technology Assessment in Health Care. 2025;41(1):e69
https://www.ncbi.nlm.nih.gov/pubmed/?otool=iaufhhslib&term=41024701
EU Joint Clinical Assessment: A Framework for Optimising Use with Cost-Effectiveness Decision-Making J Mark Access Health Policy. 2025;13(4):52
https://www.ncbi.nlm.nih.gov/pubmed/?otool=iaufhhslib&term=41142925
Health Technology Assessment of mRNA Vaccines: Clinical, Economic, and Public Health Implications Vaccines (Basel). 2025;13(10)
https://www.ncbi.nlm.nih.gov/pubmed/?otool=iaufhhslib&term=41150434
Hospital-based health technology assessment of central dialysis fluid delivery system for hemodialysis patients BMC Nephrology. 2025;26(1):590
https://www.ncbi.nlm.nih.gov/pubmed/?otool=iaufhhslib&term=41146097
An HTA systems decision-support toolbox for short and long-term healthcare and economic perspectives in an Italian hospital International Journal of Technology Assessment in Health Care. 2025;41(1):e77
https://www.ncbi.nlm.nih.gov/pubmed/?otool=iaufhhslib&term=41099256
Integrating Environmental Aspects into Health Technology Assessment: A Qualitative Study among Dutch Stakeholders International Journal of Technology Assessment in Health Care. 2025;41(1):e71
https://www.ncbi.nlm.nih.gov/pubmed/?otool=iaufhhslib&term=41048173
An Introduction to Costing and the Types of Costs Used within Health Economic Studies Pharmacoecon Open. 2025;9(6):849–868
https://www.ncbi.nlm.nih.gov/pubmed/?otool=iaufhhslib&term=41114877
MAPPING current decision-making pathways and reimbursement processes for high-risk medical devices in EU/EEA member states and the UK: a scoping review International Journal of Technology Assessment in Health Care. 2025;41(1):e78
https://www.ncbi.nlm.nih.gov/pubmed/?otool=iaufhhslib&term=41114469
NICE's early value assessment: an external assessment group's commentary on the challenges and opportunities of NICE's new life cycle approach to HealthTech International Journal of Technology Assessment in Health Care. 2025;41(1):e75
https://www.ncbi.nlm.nih.gov/pubmed/?otool=iaufhhslib&term=41126458
Patient and public involvement in health technology assessment committees: who is free from conflicts of interest? Glob Reg Health Technol Assess. 2025;12:242–244
https://www.ncbi.nlm.nih.gov/pubmed/?otool=iaufhhslib&term=41163949
Proposal of a Methodology to Enhance Mini-HTA Evaluations Studies in Health Technology and Informatics. 2025;332:227–231
https://www.ncbi.nlm.nih.gov/pubmed/?otool=iaufhhslib&term=41041779
R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 21 Journal of Comparative Effectiveness Research. 2025;14(11):e250148
https://www.ncbi.nlm.nih.gov/pubmed/?otool=iaufhhslib&term=41036833
Toward including environmental sustainability in Health Technology Assessment International Journal of Technology Assessment in Health Care. 2025;41(1):e70
https://www.ncbi.nlm.nih.gov/pubmed/?otool=iaufhhslib&term=40976996
Use of real-world data and real-world evidence in NICE (UK) health technology appraisals of new therapeutics in oncology: a systematic review BMJ Open. 2025;15(9):e102769
https://www.ncbi.nlm.nih.gov/pubmed/?otool=iaufhhslib&term=41022438
The use of real-world evidence among healthcare payers: a scoping review International Journal of Technology Assessment in Health Care. 2025;41(1):e67
https://www.ncbi.nlm.nih.gov/pubmed/?otool=iaufhhslib&term=40936210
Which Factors are Holding up the Integration of the Environmental Impact of Health Technologies in Health Technology Assessment? Insights from a Multi-Stakeholder Interview Study Applied Health Economics and Health Policy. 2025
https://www.ncbi.nlm.nih.gov/pubmed/?otool=iaufhhslib&term=41148542
No Subjects
10/01/2025
Access in all areas? A round up of developments in market access and health technology assessment: part 9 Journal of Comparative Effectiveness Research. 2025;14(10):e250120
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40767045
Access in all areas? A round-up of developments in market access and health technology assessment: part 10 Journal of Comparative Effectiveness Research. 2025:e250138
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40955618
Artificial intelligence in key pricing, reimbursement, and market access (PRMA) processes: better, faster, cheaper-can you really pick two? Journal of Medical Economics. 2025;28(1):586–595
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40167461
Composite endpoints in health technology assessment: Part 1 - an illustration of best modeling practice Journal of Comparative Effectiveness Research. 2025;14(10):e240117
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40927977
Composite endpoints in health technology assessment: Part 2 - expanding the evidence base with a framework for best modeling practice Journal of Comparative Effectiveness Research. 2025;14(10):e250012
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40927978
Cost Comparisons in NICE Technology Appraisals: An External Assessment Group Perspective Pharmacoeconomics. 2025;43(10):1165–1169
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40699293
Early health technology assessment: current and future perspectives from a health technology assessment agency International Journal of Technology Assessment in Health Care. 2025;41(1):e68
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40958666
Early-stage assessment of investigational digital technologies in mental health: a guide for innovators Psychiatry Research. 2025;351:116634
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40743859
European Health Technology Assessment Considerations Related to Gene Therapies in Eyecare: The Neovascular Age-Related Macular Degeneration Example J Mark Access Health Policy. 2025;13(3):42
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40989744
FRAME: Framework for Real-World Evidence Assessment to Mitigate Evidence Uncertainties for Efficacy/Effectiveness - An Evaluation of Regulatory and Health Technology Assessment Decision Making Clinical Pharmacology and Therapeutics. 2025;118(3):649–661
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40493357
A Framework for Considering the Role of the Public Sector in R&D of Health Technology Pharmaceutical Medicine. 2025;39(5):325–340
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40779237
HTA Evidence in Rare Diseases: Just Rare or Also Special? Pharmacoeconomics. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40924270
Integrating Environmental Impact in Health Technology Assessment: An Exploratory Study Pharmacoeconomics. 2025;43(10):1205–1222
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40682640
Is Innovation Worth the Price? Cost-Effectiveness Analysis in Interventional Oncology Cardiovascular and Interventional Radiology. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41016947
Personalised exercise-rehabilitation for people with multiple long-term conditions (PERFORM): a randomised feasibility study BMJ Open. 2025;15(9):e100195
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40967655
The PICO Puzzle: Can Public Data Predict EU HTA Expectations for All EU Countries? J Mark Access Health Policy. 2025;13(3):32
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40709217
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 20 Journal of Comparative Effectiveness Research. 2025;14(9):e250113
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40698536
Transportability of nonlocal real-world evidence and its relevance to health technology assessment: a primer Journal of Comparative Effectiveness Research. 2025;14(10):e250041
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40836909
Use of real-world data and real-world evidence in NICE (UK) health technology appraisals of new therapeutics in oncology: a systematic review BMJ Open. 2025;15(9):e102769
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41022438
Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease EClinicalMedicine. 2025;88:103465
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40932851
Why drugs fail health technology assessment: a comparative analysis of health technology assessment rejections across seven OECD countries Health Econ Policy Law. 2025;20(3):264–283
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40922553
No Subjects
09/03/2025
Building Lay Society Knowledge and Education for Health Technology Assessment and Policy Engagement: Case of CFTR Modulator Access in Brazil Healthcare (Basel). 2025;13(16)
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40868613
Choosing to Implement Value-Based Healthcare Initiatives: A Strategic Decision for Achieving Better Performance in Improving Population Health Comment on "Reflections on Managing the Performance of Value-Based Healthcare: A Scoping Review" Int J Health Policy Manag. 2025;14:9050
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40767201
Comprehensive analysis of frameworks for evaluating artificial intelligence solutions in Healthcare: A descriptive review Computers in Biology and Medicine. 2025;196(Pt B):110750
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40695025
Distributional cost-effectiveness analysis and health technology assessment at NICE: a response to Ramagopalan Value in Health. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40812750
Early-stage assessment of investigational digital technologies in mental health: a guide for innovators Psychiatry Research. 2025;351:116634
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40743859
Extensive digital health technology assessment detects subtle motor impairment in mild and asymptomatic Pompe disease Scientific Reports. 2025;15(1):29798
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40813881
FRAME: Framework for Real-World Evidence Assessment to Mitigate Evidence Uncertainties for Efficacy/Effectiveness - An Evaluation of Regulatory and Health Technology Assessment Decision Making Clinical Pharmacology and Therapeutics. 2025;118(3):649–661
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40493357
A Framework for Considering the Role of the Public Sector in R&D of Health Technology Pharmaceutical Medicine. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40779237
Health Technology Assessment of Continuous Glucose Monitoring Systems for Paediatric Patients Children (Basel). 2025;12(8)
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40868539
The Importance of a Methodological Manual for Economic Evaluations in Healthcare Decision-Making in Ecuador Pharmacoecon Open. 2025;9(5):713–722
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40450645
Including Productivity as an Element to Reflect Value of the Treatment: A Systematic Review of Published Health Economic Evaluations Pharmacoecon Open. 2025;9(5):723–738
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40553408
Methodological approaches in the economic evaluation of prognostic and predictive companion diagnostics: a systematic scoping review Expert Review of Pharmacoeconomics & Outcomes Research. 2025;25(7):1037–1049
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40518839
Patient Involvement in Health Technology Assessments: Lessons for EU Joint Clinical Assessments J Mark Access Health Policy. 2025;13(3):38
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40860957
Pivotal Studies for Drugs About to Be Launched for Rare Diseases: Will They Better Support Health Technology Assessment and Market Access than in the Past? J Mark Access Health Policy. 2025;13(3):37
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40860956
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 20 Journal of Comparative Effectiveness Research. 2025;14(9):e250113
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40698536
Selecting Cost-Effectiveness Methods for Health Benefits Package Design: A Systematic Approach Int J Health Policy Manag. 2025;14:8562
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40767209
A Systematic Review and Quality Assessment of Pharmacoeconomic Publications for China Compared to Internationally: Is the Quality of Evidence-Base Sufficient for Health Technology Assessment? Int J Health Policy Manag. 2025;14:8656
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40767195
Transportability of nonlocal real-world evidence and its relevance to health technology assessment: a primer Journal of Comparative Effectiveness Research. 2025:e250041
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40836909
Use of patient-reported outcome measures in cost-effectiveness models informing health technology assessments of non-oncology treatments: a review Journal of Medical Economics. 2025;28(1):1045–1060
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40635626
Value-Based Framework for Evaluating Pre-Commercial Procurement: Case Study of Value-Based Key Performance Indicators JMIR Form Res. 2025;9:e71279
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40811851
No Subjects
08/06/2025
The Acceptance of Overall Survival Extrapolation Methods in Solid Tumor Treatments by Health Technology Assessment Agencies in England, France, and Australia between 2017 and 2022 Medical Decision Making. 2025:272989x251351635
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40751431
Access in all areas? A round up of developments in market access and health technology assessment: part 8 Journal of Comparative Effectiveness Research. 2025;14(8):e250091
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40524671
Achieving Patient-Centered Value/Health Technology Assessment: Recommendations From a Multistakeholder eDelphi Panel Value in Health. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40633728
Applying early health technology assessment (e-HTA) to inform investment in novel health technologies in the US International Journal of Technology Assessment in Health Care. 2025;41(1):e45
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40625059
Are we properly evaluating genetic and genomic testing? A systematic review of health technology assessment reports Journal of Translational Medicine. 2025;23(1):749
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40624720
CAR-T cell therapies: patient access and affordability solutions Future Sci OA. 2025;11(1):2483613
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40156283
Cessation of smoking in people attending UK emergency departments: the COSTED RCT with economic and process evaluation Health Technology Assessment. 2025;29(35):1-36
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40748216
Challenges in Modelling the Cost Effectiveness of Pharmacotherapies for Obesity Pharmacoeconomics. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40717166
A Comprehensive View of the Methods Used to Measure the Societal Impact of Healthcare Interventions: A Systematic Review Value in Health. 2025;28(8):1288-1299
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40049328
Connecting minds and catalyzing collaboration: the interest groups of health technology assessment international International Journal of Technology Assessment in Health Care. 2025;41(1):e43
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40619817
Cost Comparisons in NICE Technology Appraisals: An External Assessment Group Perspective Pharmacoeconomics. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40699293
The Evolving Landscape of Discrete Choice Experiments in Health Economics: A Systematic Review Pharmacoeconomics. 2025;43(8):879-936
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40397369
Global research on patient involvement in health technology assessment: a bibliometric analysis Global Health Research and Policy. 2025;10(1):30
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40713904
Identification and Description of Regulatory and Health Technology Assessment Agencies' Guidance Related to Patient Experience Data in North America, Europe, and Asia Pacific Ther Innov Regul Sci. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40676467
Institutionalization of Health Technology Assessment of medical devices: a cluster analysis of EU, EEA, and EFTA countries International Journal of Technology Assessment in Health Care. 2025;41(1):e44
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40625064
Integrating Environmental Impact in Health Technology Assessment: An Exploratory Study Pharmacoeconomics. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40682640
Invasive urodynamic investigations in the management of women with refractory overactive bladder symptoms: FUTURE, a superiority RCT and economic evaluation Health Technology Assessment. 2025;29(27):1-139
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40620147
Navigating the future: horizon scanning and early dialogue in health technology assessment in Latin America International Journal of Technology Assessment in Health Care. 2025;41(1):e42
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40637451
Reflecting Social Values in HTA Methods: A Case Study of South Africa Applied Health Economics and Health Policy. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40660007
A systematic review of health economic evaluation quality assessment instruments for medical devices International Journal of Technology Assessment in Health Care. 2025;41(1):e40
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40638846
Towards the Operationalization of Health Technology Sustainability Assessment and the Early Eco Design of the Internet of Medical Things Sensors (Basel). 2025;25(13)
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40648098
Use of patient-reported outcome measures in cost-effectiveness models informing health technology assessments of non-oncology treatments: a review Journal of Medical Economics. 2025;28(1):1045-1060
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40635626
No Subjects
07/02/2025
Access in all areas? A round up of developments in market access and health technology assessment: part 8 Journal of Comparative Effectiveness Research. 2025:e250091
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40524671
Applications of artificial intelligence and the challenges in health technology assessment: a scoping review and framework with a focus on economic dimensions Health Econ Rev. 2025;15(1):46
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40461901
CAR-T cell therapies: patient access and affordability solutions Future Sci OA. 2025;11(1):2483613
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40156283
Clinical equivalence and non-inferiority within health technology assessment European Journal of Health Economics. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40506597
Defining Biological and Clinical Plausibility: The DICSA Framework for Protocolized Assessment in Survival Extrapolations Across Therapeutic Areas Pharmacoeconomics. 2025;43(7):793-803
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40156682
Defining early health technology assessment: building consensus using Delphi technique International Journal of Technology Assessment in Health Care. 2025;41(1):e34
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40452233
Defining early health technology assessment: reclaiming origins and diversity of applications International Journal of Technology Assessment in Health Care. 2025;41(1):e35
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40452383
Development and validation of a type 2 diabetes model to estimate the cost-effectiveness of diabetes interventions across the care continuum International Journal of Technology Assessment in Health Care. 2025;41(1):e36
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40452371
Evaluating Digital Health Solutions in Diabetes and the Role of Patient-Reported Outcomes: Targeted Literature Review JMIR Diabetes. 2025;10:e52909
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40466203
Exploring the Economic Burden of Pulmonary Arterial Hypertension and Its Relation to Disease Severity and Treatment Escalation: A Systematic Literature Review Pharmacoeconomics. 2025;43(7):741-760
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40244370
FRAME: Framework for Real-World Evidence Assessment to Mitigate Evidence Uncertainties for Efficacy/Effectiveness - An Evaluation of Regulatory and Health Technology Assessment Decision Making Clinical Pharmacology and Therapeutics. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40493357
Health Technology Assessment and Cardiology: A Review of the Present and Future of Innovation J Mark Access Health Policy. 2025;13(2):30
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40568382
Health Technology Assessment and Environmental Impact: A Scoping Review of State of Art and Future Perspective Applied Health Economics and Health Policy. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40549262
Including Productivity as an Element to Reflect Value of the Treatment: A Systematic Review of Published Health Economic Evaluations Pharmacoecon Open. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40553408
Methodological approaches in the economic evaluation of prognostic and predictive companion diagnostics: a systematic scoping review Expert Review of Pharmacoeconomics & Outcomes Research. 2025:1-13
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40518839
Patient Engagement and Patient Experience Data in Regulatory Review and Health Technology Assessment: Where Are We Today? Ther Innov Regul Sci. 2025;59(4):737-752
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40210822
Preparing future healthcare professionals for evidence-based decision-making using health technology assessment as an experiential learning tool Medical Teacher. 2025;47(7):1097-1099
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39663157
Quality in qualitative evidence: new best practice principles from NICE’s real-world evidence framework Journal of Comparative Effectiveness Research. 2025;14(7):e250064
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40511737
Quantifying the cost savings and health impacts of improving colonoscopy quality: an economic evaluation BMJ Qual Saf. 2025;34(7):469-478
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38925929
Rapid health technology assessment of galantamine for the treatment of Alzheimer’s disease: A review Medicine (Baltimore). 2025;104(23):e42744
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40489822
Selection and Prioritization of Medical Devices for HTA Evaluation: A Systematic Review of Existing Approaches Applied Health Economics and Health Policy. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40483311
Supporting translation with early health technology assessment: from definition to action International Journal of Technology Assessment in Health Care. 2025;41(1):e39
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40452623
No Subjects
06/04/2025
Access in all areas? A round up of developments in market access and health technology assessment: part 7 Journal of Comparative Effectiveness Research. 2025;14(6):e250043
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40223528
CAR-T cell therapies: patient access and affordability solutions Future Sci OA. 2025;11(1):2483613
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40156283
Challenges and reforms in Spain's health technology assessment system: analysis of criteria influencing medicines' reimbursement decisions between 2019 and 2022 in Spain European Journal of Health Economics. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40343653
Clinical and cost-effectiveness of detailed anomaly ultrasound screening in the first trimester: a mixed-methods study Health Technology Assessment. 2025;29(22):1-250
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40455571
Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression in adults: LQD a pragmatic randomised controlled trial Health Technology Assessment. 2025;29(12):1-118
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40350798
Cost-utility analysis of the DREAMS START intervention for people living with dementia and their carers: a within-trial economic evaluation Lancet Healthy Longev. 2025;6(5):100708
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40412418
DEFINING EARLY HEALTH TECHNOLOGY ASSESSMENT: BUILDING CONSENSUS USING DELPHI TECHNIQUE International Journal of Technology Assessment in Health Care. 2025:1-27
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40452233
Early access to medicines with added therapeutic value: Measuring and comparing time to medicines access in England, France, Germany, Italy and Spain Health Policy. 2025;157:105317
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40300221
ESR Essentials: how to get to valuable radiology AI: the role of early health technology assessment-practice recommendations by the European Society of Medical Imaging Informatics European Radiology. 2025;35(6):3432-3441
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39636421
The Evolving Landscape of Discrete Choice Experiments in Health Economics: A Systematic Review Pharmacoeconomics. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40397369
The global landscape of country-level health technology assessment processes: A survey among 104 countries Health Policy Open. 2025;8:100138
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40236923
How similar is similar enough? Assessment of indirect treatment comparisons to support similarity for NICE's cost comparison route Value in Health. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40414457
The Importance of a Methodological Manual for Economic Evaluations in Healthcare Decision-Making in Ecuador Pharmacoecon Open. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40450645
Pricing combination products: not how but who? European Journal of Health Economics. 2025;26(4):537-540
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40244483
Rapid tests to inform triage and antibiotic prescribing decisions for adults presenting with suspected acute respiratory infection: a rapid evidence synthesis of clinical effectiveness and cost-utility studies Health Technology Assessment. 2025;29(13):1-114
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40380815
Redefining value assessment and healthcare funding priorities for medicines: the journey to patient-centric decision making in APAC - a systematic literature review International Journal of Technology Assessment in Health Care. 2025;41(1):e28
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40365699
Regional Citrate Anticoagulation Versus Systemic Heparin in Continuous Kidney Replacement Therapy: Examining the Role of Evidence in Health Technology Assessment Advances in Therapy. 2025;42(6):2606-2638
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40238058
Regulatory landscape of accelerated approval pathways for medical devices in the United States and the European Union Front Med Technol. 2025;7:1586070
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40444060
Software with artificial intelligence-derived algorithms for detecting and analysing lung nodules in CT scans: systematic review and economic evaluation Health Technology Assessment. 2025;29(14):1-234
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40380885
Stakeholders' Perspectives on Medication Adherence Enhancing Interventions Value in Health. 2025;28(5):676-679
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40340081
Strengthening the EU Health Technology Assessment Regulation: Integrating National Immunization Technical Advisory Groups for Comprehensive Vaccine Assessments J Mark Access Health Policy. 2025;13(2):16
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40276092
No Subjects
05/07/2025
CAR-T cell therapies: patient access and affordability solutions Future Sci OA. 2025;11(1):2483613
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40156283
Decision-Analytical Modelling of Medicines in the Middle East: A Systematic Review of Economic Evaluation Studies Applied Health Economics and Health Policy. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40221639
Different attitudes towards estimating indirect costs of disease: The example of cancer J Public Health Res. 2025;14(2):22799036251326636
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40296884
Early access to medicines with added therapeutic value: Measuring and comparing time to medicines access in England, France, Germany, Italy and Spain Health Policy. 2025;157:105317
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40300221
Examining Consistency Across NICE Single Technology Appraisals: A Review of Appraisals for Paroxysmal Nocturnal Haemoglobinuria Pharmacoeconomics. 2025;43(5):499-508
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39934600
Importance of Health Economics and Outcomes Research in the Product Lifecycle Pharmaceutical Medicine. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40227495
Is this test fit-for-purpose? Principles and a checklist for evaluating the clinical performance of a test in the new era of in vitro diagnostic (IVD) regulation Critical Reviews in Clinical Laboratory Sciences. 2025;62(3):182-197
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39912349
Learning strategies for laypeople to participate in health technology assessment: a scoping review International Journal of Technology Assessment in Health Care. 2025;41(1):e26
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40223508
Mapping methods gaps between EU joint clinical assessments and local health technology assessment decision-making: an environmental scan of guidance in select EU markets and harmonization challenges Journal of Comparative Effectiveness Research. 2025;14(5):e240240
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40008768
Matching-Adjusted Indirect Comparison Studies in Oncology: A Scoping Review Focused on Reporting Quality Value Health Reg Issues. 2025;47:101088
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39999561
The need to consider market access for pharmaceutical investment decisions: a primer Journal of Comparative Effectiveness Research. 2025;14(5):e250036
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40183520
Regional Citrate Anticoagulation Versus Systemic Heparin in Continuous Kidney Replacement Therapy: Examining the Role of Evidence in Health Technology Assessment Advances in Therapy. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40238058
The role and value of real-world evidence in health technology decision-making in France, Germany, Italy, Spain, and the UK: insights on external control arms International Journal of Technology Assessment in Health Care. 2025;41(1):e25
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40260460
Strengthening health technology assessment for cancer treatments in Europe by integrating causal inference and target trial emulation Lancet Reg Health Eur. 2025;52:101294
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40255411
A Systematic Review of Economic Evaluations in Clinical Nursing Practices Journal of Nursing Management. 2024;2024:9939254
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40224743
Using Real-World Evidence for Clinical Development to Address the Gap Between Marketing Authorisation and Reimbursement in European Countries: Insights From Literature Review Journal of Evaluation in Clinical Practice. 2025;31(3):e70090
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40189820
Utility Studies in Rare Diseases: A Systematic Literature Review Value in Health. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40220862
No Subjects
04/02/2025
Advancing Principled Pharmacoepidemiologic Research to Support Regulatory and Healthcare Decision Making: The Era of Real-World Evidence Clinical Pharmacology and Therapeutics. 2025;117(4):927-937
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39807817
"Blanket rules just don't work": Qualitative exploration of the relative value of child and adult Quality Adjusted Life Year (QALY) gains for health technology assessment International Journal of Technology Assessment in Health Care. 2025:1-34
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40151870
CAR-T cell therapies: patient access and affordability solutions Future Sci OA. 2025;11(1):2483613
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40156283
A Comprehensive View of the Methods Used to Measure the Societal Impact of Healthcare Interventions: A Systematic Review Value in Health. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40049328
Economic Evaluations of Treatment of Depressive Disorders in Adolescents: A Scoping Review Value in Health. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40049329
Enhancing systematic literature reviews with generative artificial intelligence: development, applications, and performance evaluation Journal of the American Medical Informatics Association. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40036547
Guidance for an Effective Approach to Integrated Evidence Planning in a Dynamic World Clinical Pharmacology and Therapeutics. 2025;117(4):920-926
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39789863
Harmonizing HTA Evidence Needs and Expectations: Challenges and Opportunities to Improve Evidence Generation, Ensure Access and Affordability Clinical Pharmacology and Therapeutics. 2025;117(4):938-945
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39972486
Harnessing health technology assessment in India: paving the way for sustainable healthcare solutions in developing countries BMJ Evidence Based Medicine. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40037703
Hospital admissions attributable to reduced air pollution due to clean-air policies in China Nature Medicine. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40087514
Is health technology assessment value for money? Estimating the return on investment of health technology assessment in India (HTAIn) BMJ Evidence Based Medicine. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40113231
Methods for the health technology assessment of complex interventions: A scoping review PloS One. 2025;20(3):e0315381
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40085544
Navigating barriers to health technology assessment development in Iran: a qualitative exploration of stakeholder perspectives Arch Public Health. 2025;83(1):83
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40148921
NAVIGATING CHANGE: A COMPARATIVE ANALYSIS OF HEALTH TECHNOLOGY ASSESSMENT REFORMS ACROSS AGENCIES - PROCESSES, DRIVERS, AND INTERDEPENDENCIES International Journal of Technology Assessment in Health Care. 2025:1-30
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40083319
New IPECAD Open-Source Model Framework for the Health Technology Assessment of Early Alzheimer's Disease Treatment: Development and Use Cases Value in Health. 2025;28(4):511-518
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39094686
PATIENT ENGAGEMENT FOR THE DEVELOPMENT OF EQUITY-FOCUSED HEALTH TECHNOLOGY ASSESSMENT (HTA) RECOMMENDATIONS: A CASE STUDY OF TWO CANADIAN HTA ORGANIZATIONS International Journal of Technology Assessment in Health Care. 2025:1-28
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40151855
Planning Post-Launch Evidence Generation: Lessons From France, England and Spain Clinical Pharmacology and Therapeutics. 2025;117(4):961-966
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39960266
The potential of the hospital-based Health Technology Assessment: Results of a world-wide survey International Journal of Technology Assessment in Health Care. 2025;41(1):e19
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40099540
PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods BMJ. 2025;388:e082505
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40127903
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 18 Journal of Comparative Effectiveness Research. 2025;14(4):e250014
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39963965
Role of Health Equity in Health Technology Assessment Processes: A Landscape Analysis of 13 Health Systems in Asia Value in Health. 2025;28(4):582-590
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39922297
Selection of indirect treatment comparisons for health technology assessments: a practical guide for health economics and outcomes research scientists and clinicians BMJ Open. 2025;15(3):e091961
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40132816
Uncertainty in Matching-Adjusted Indirect Comparisons Using Real-World Evidence: Evidence Assessment Group Perspective Pharmacoeconomics. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40117115
Use of Real-World Evidence in Health Technology Reassessments Across Six Health Technology Assessment Agencies Value in Health. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40054770
Using natural experiments to evaluate population health and health system interventions: new framework for producers and users of evidence BMJ. 2025;388:e080505
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40154983
No Subjects
03/06/2025
AI for IMPACTS Framework for Evaluating the Long-Term Real-World Impacts of AI-Powered Clinician Tools: Systematic Review and Narrative Synthesis Journal of Medical Internet Research. 2025;27:e67485
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39909417
Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis: The ADAPT-Sepsis Randomized Clinical Trial JAMA. 2025;333(8):682-693
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39652885
Clinical and cost-effectiveness of a home-based health promotion intervention for older people with mild frailty in England: a multicentre, parallel-group, randomised controlled trial Lancet Healthy Longev. 2025;6(2):100670
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40015296
Clinical trials for implantable neural prostheses: understanding the ethical and technical requirements Lancet Digit Health. 2025;7(3):e216-e224
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39794174
Economic Evaluation of Robotic-assisted Radical Prostatectomy: A Systematic Review and Meta-analysis Eur Urol Open Sci. 2025;72:17-28
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39996029
Enhancing systematic literature reviews with generative artificial intelligence: development, applications, and performance evaluation Journal of the American Medical Informatics Association. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40036547
ENIGMA-shock: protocol for a study framEwork for aN InteGrated assessMent of cArdiac rehabilitation programmes in patients acutely managed for cardiogenic shock BMJ Open. 2025;15(2):e092790
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39938955
Harnessing health technology assessment in India: paving the way for sustainable healthcare solutions in developing countries BMJ Evidence Based Medicine. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40037703
Is this test fit-for-purpose? Principles and a checklist for evaluating the clinical performance of a test in the new era of in vitro diagnostic (IVD) regulation Critical Reviews in Clinical Laboratory Sciences. 2025:1-16
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39912349
Mapping the Landscape of Open Source Health Economic Models: A Systematic Database Review and Analysis Value in Health. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39952464
Mentalisation-based treatment for antisocial personality disorder in males convicted of an offence on community probation in England and Wales (Mentalization for Offending Adult Males, MOAM): a multicentre, assessor-blinded, randomised controlled trial Lancet Psychiatry. 2025;12(3):208-219
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39978982
Methods and Practical Considerations for Conducting Budget Impact Analysis for Non-Pharmaceutical Interventions Applied Health Economics and Health Policy. 2025;23(2):197-208
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39820973
Patient-Informed Value Elements in Cost-Effectiveness Analyses of Major Depressive Disorder Treatment: A Literature Review and Synthesis Value in Health. 2025;28(3):399-405
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38852668
Prevalence of Immature Survival Data for Anticancer Drugs Presented to the National Institute for Health and Care Excellence Between 2018 and 2022 Value in Health. 2025;28(3):406-414
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39725010
Reporting of Patient and Public Involvement in Technology Appraisal and Assessment Reports: A Rapid Scoping Review Patient. 2025;18(2):109-114
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39487952
Systematic Literature Review of Access Pathways to Drugs for Patients with Rare Diseases Applied Health Economics and Health Policy. 2025;23(2):209-229
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39731657
Understanding "Alert Fatigue" in Primary Care: Qualitative Systematic Review of General Practitioners Attitudes and Experiences of Clinical Alerts, Prompts, and Reminders Journal of Medical Internet Research. 2025;27:e62763
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39918864
Understanding the effectiveness and underlying mechanisms of lifestyle modification interventions in adults with learning disabilities: a mixed-methods systematic review Health Technology Assessment. 2025;29(4):1-168
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40025754
Use of surrogate endpoints in health technology assessment: a review of selected NICE technology appraisals in oncology International Journal of Technology Assessment in Health Care. 2025;41(1):e11
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39967232
Uterine rupture following prostaglandins use in second trimester medical abortion: Fact or fiction? A systematic review International Journal of Gynaecology and Obstetrics. 2025;168(3):875-892
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39377762
Value and Implementation of Patient and Public Involvement and Engagement in Health Technology Assessment for Japan: implications from systematic searches International Journal of Technology Assessment in Health Care. 2025;41(1):e14
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40017112
No Subjects
02/05/2025
Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and older in the UK (Mammo-50): a multicentre, randomised, phase 3, non-inferiority trial Lancet. 2025;405(10476):396-407
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39892911
Case for a health equity framework in health technology assessment Lancet. 2025;405(10476):376-377
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39892901
Celebrating 30 years of the international network of agencies for health technology assessment (INAHTA) International Journal of Technology Assessment in Health Care. 2025;41(1):e7
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39895096
Clinical trials for implantable neural prostheses: understanding the ethical and technical requirements Lancet Digit Health. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39794174
Comparison of health technology assessments for digital therapeutics in Germany, the United Kingdom and France Digit Health. 2025;11:20552076241308704
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39845519
Efficacy, safety and cost-effectiveness of obinutuzumab in patients with follicular lymphoma: a rapid review Frontiers in Pharmacology. 2024;15:1426772
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39830356
Evidence generation throughout paediatric medicines life cycle: findings from collaborative work between European Medicines Agency (EMA) and EUnetHTA on use of extrapolation British Journal of Pharmacology. 2025;182(3):484-494
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39574299
Financial challenges of being on long-term, high-cost medications Neurooncol Pract. 2025;12(Suppl 1):i49-i58
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39776525
Generative Artificial Intelligence for Health Technology Assessment: Opportunities, Challenges, and Policy Considerations: An ISPOR Working Group Report Value in Health. 2025;28(2):175-183
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39536966
Guidance for an Effective Approach to Integrated Evidence Planning in a Dynamic World Clinical Pharmacology and Therapeutics. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39789863
Hospital-based health technology assessment (HTA) in Latin America and the Caribbean: a scoping review Revista Panamericana de Salud Publica. 2025;49:e8
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39811043
How can actuarial science contribute to the field of health technology assessment? An interdisciplinary perspective International Journal of Technology Assessment in Health Care. 2025;41(1):e3
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39757736
MRI-assessed Dynamic Hyperinflation Induced by Tachypnea in Chronic Obstructive Pulmonary Disease: The SPIROMICS-HF Study Radiol Cardiothorac Imaging. 2025;7(1):e240053
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39836055
Multi-cancer early detection tests for general population screening: a systematic literature review Health Technology Assessment. 2025;29(2):1-105
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39898371
Multiple Perspectives on the Need for Real-World Evidence to Inform Regulatory and Health Technology Assessment Decision-Making: Scoping Review and Stakeholder Interviews Pharmacoepidemiology and Drug Safety. 2025;34(1):e70074
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39777765
The Paradigm Shift From Patient to Health Consumer: 20 Years of Value Assessment in Health Journal of Medical Internet Research. 2025;27:e60443
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39793021
Post-Market Evidence for Cancer Medicines in Regulatory and Clinical Decision-Making: A Scoping Review Pharmacoepidemiology and Drug Safety. 2025;34(1):e70093
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39805804
Revising EU pharmaceutical legislation: will it foster drug repurposing? Drug Discov Today. 2025;30(1):104286
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39756647
A Systematic Literature Review of Modelling Approaches to Evaluate the Cost Effectiveness of PET/CT for Therapy Response Monitoring in Oncology Pharmacoeconomics. 2025;43(2):133-151
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39488797
A systematic review of the cost-effectiveness of anti-VEGF drugs for the treatment of diabetic retinopathy Health Technology Assessment. 2025:1-19
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39881630
The Use of Real-World Data for Estimating Relative Treatment Effects in NICE Health Technology Assessment Submissions: A Review Pharmacoeconomics. 2025;43(2):123-131
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39520643
No Subjects